Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Precision BioSciences, Inc. (DTIL) had Debt to Equity Ratio of 0.49 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-32.65M |
|
-- |
|
-- |
|
$19.16M |
|
$-19.16M |
|
$-13.49M |
|
$-32.65M |
|
$-32.65M |
|
$-32.65M |
|
$-32.65M |
|
$-32.65M |
|
$-32.65M |
|
$-19.16M |
|
$-18.56M |
|
25.86M |
|
25.86M |
|
$-1.26 |
|
$-1.26 |
|
| Balance Sheet Financials | |
$91.55M |
|
$0.96M |
|
$34.37M |
|
$125.92M |
|
$7.14M |
|
$22.42M |
|
$73.49M |
|
$80.63M |
|
$45.29M |
|
$44.20M |
|
$45.29M |
|
26.43M |
|
| Cash Flow Statement Financials | |
$-25.38M |
|
$-0.11M |
|
$0.74M |
|
$137.15M |
|
$112.41M |
|
$-24.75M |
|
$3.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.82 |
|
-- |
|
-- |
|
0.33 |
|
|
Debt to Equity Ratio |
0.49 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-72.09% |
|
-73.87% |
|
-25.93% |
|
-48.22% |
|
$1.71 |
|
$-0.98 |
|
$-0.98 |
|